Andrew is a Partner in Trinity’s Value, Access and Pricing practice and has over 15 years working within the Life Sciences arena. Prior to joining Trinity, he led CBPartners’ U.S. Center of Excellence and focused on managed markets strategy engagements. His experience has emphasized the development of numerous pricing and access strategies for both pre-launch and in-line assets within the U.S. Specifically, Andrew supports asset development through various engagements, including: early stage/launch pricing, innovative and traditional contracting strategy, market access assessment, target product profile & optimized trial design review and value message development/testing.

Andrew also has extensive experience engaging with payers and other healthcare stakeholders (i.e. physicians, GPOs, SPs, etc.) through various qualitative research methodologies, including in-depth interviews, dyads, live panels/ad-boards and virtual panels. Additionally, he has led engagements involving quantitative surveys and comprehensive data analyses.

Earlier in his career, Andrew spent over five years with PriceSpective (ICON). Andrew holds a MS in Biotechnology from Middle Tennessee State University and a BS in Biomedical Science from Auburn University.